Patent ID: 9255087
Filing Date: 2016-02-09
CPC Classification: A61K,A61P,C07D

Claim Text:
1. A method for treating a disease selected from breast cancer, lung cancer, non-small cell lung cancer, colorectal cancer, prostate cancer, ovarian cancer, endometrial cancer, gastric cancer, clear cell renal cell carcinoma, uveal melanoma, multiple myeloma, rhabdomyosarcoma, Ewing's sarcoma, Kaposi's sarcoma, medulloblastoma, anaplastic large cell lymphoma, neuroblastoma, rhabdomyosarcoma, glioblastoma, inflammatory myofibroblastic tumor, melanomas, Ewing's sarcomas, retinoblastomas, squamous cell carcinoma, seminoma, teratocarcinoma, xeroderma pigmentosum, and thyroid follicular cancer, said method comprising administering to a patient in need thereof an amount of N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide, or a pharmaceutically acceptable salt thereof, effective to treat said disease.